Biosimulation is computer-aided mathematical simulation of biological processes and systems and thus is an integral part of systems biology.
Scope of the Report:
This report focuses on the Bio Simulation in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Bio Simulation is expected to grow at a CAGR of roughly xx% over the next five years, will reach 1100 million US$ in 2023, from 1100 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Certara USA, Inc.
Simulation Plus Inc.
Dassault Systèmes SA
Medtronic
Advanced Chemistry Development, Inc.
Chemical Computing Group, Inc.
Entelos Holding Corporation
Genedata AG
Physiomics PLC
Rhenovia Pharma Ltd.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
For Drug Development
For Drug Discovery
Other
Market Segment by Applications, can be divided into
Pharmaceutical and Biotechnology Companies
Academic and Government Research Institutes
Contract Research Organizations
Regulatory Authorities
Other End Users
There are 15 Chapters to deeply display the global Bio Simulation market.
Chapter 1, to describe Bio Simulation Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Bio Simulation, with sales, revenue, and price of Bio Simulation, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Bio Simulation, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Bio Simulation market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Bio Simulation sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Bio Simulation Introduction
1.2 Market Analysis by Type
1.2.1 For Drug Development
1.2.2 For Drug Discovery
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 Pharmaceutical and Biotechnology Companies
1.3.2 Academic and Government Research Institutes
1.3.3 Contract Research Organizations
1.3.4 Regulatory Authorities
1.3.5 Other End Users
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Certara USA, Inc.
2.1.1 Business Overview
2.1.2 Bio Simulation Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Certara USA, Inc. Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Simulation Plus Inc.
2.2.1 Business Overview
2.2.2 Bio Simulation Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Simulation Plus Inc. Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Dassault Systèmes SA
2.3.1 Business Overview
2.3.2 Bio Simulation Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Dassault Systèmes SA Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Medtronic
2.4.1 Business Overview
2.4.2 Bio Simulation Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Medtronic Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Advanced Chemistry Development, Inc.
2.5.1 Business Overview
2.5.2 Bio Simulation Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Advanced Chemistry Development, Inc. Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Chemical Computing Group, Inc.
2.6.1 Business Overview
2.6.2 Bio Simulation Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Chemical Computing Group, Inc. Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Entelos Holding Corporation
2.7.1 Business Overview
2.7.2 Bio Simulation Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Entelos Holding Corporation Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Genedata AG
2.8.1 Business Overview
2.8.2 Bio Simulation Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Genedata AG Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Physiomics PLC
2.9.1 Business Overview
2.9.2 Bio Simulation Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Physiomics PLC Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Rhenovia Pharma Ltd.
2.10.1 Business Overview
2.10.2 Bio Simulation Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Rhenovia Pharma Ltd. Bio Simulation Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bio Simulation Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Bio Simulation Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Bio Simulation Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Bio Simulation Manufacturer Market Share in 2017
3.3.2 Top 6 Bio Simulation Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Bio Simulation Market Analysis by Regions
4.1 Global Bio Simulation Sales, Revenue and Market Share by Regions
4.1.1 Global Bio Simulation Sales and Market Share by Regions (2013-2018)
4.1.2 Global Bio Simulation Revenue and Market Share by Regions (2013-2018)
4.2 North America Bio Simulation Sales and Growth Rate (2013-2018)
4.3 Europe Bio Simulation Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Bio Simulation Sales and Growth Rate (2013-2018)
4.5 South America Bio Simulation Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Bio Simulation Sales and Growth Rate (2013-2018)
5 North America Bio Simulation by Countries
5.1 North America Bio Simulation Sales, Revenue and Market Share by Countries
5.1.1 North America Bio Simulation Sales and Market Share by Countries (2013-2018)
5.1.2 North America Bio Simulation Revenue and Market Share by Countries (2013-2018)
5.2 United States Bio Simulation Sales and Growth Rate (2013-2018)
5.3 Canada Bio Simulation Sales and Growth Rate (2013-2018)
5.4 Mexico Bio Simulation Sales and Growth Rate (2013-2018)
6 Europe Bio Simulation by Countries
6.1 Europe Bio Simulation Sales, Revenue and Market Share by Countries
6.1.1 Europe Bio Simulation Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Bio Simulation Revenue and Market Share by Countries (2013-2018)
6.2 Germany Bio Simulation Sales and Growth Rate (2013-2018)
6.3 UK Bio Simulation Sales and Growth Rate (2013-2018)
6.4 France Bio Simulation Sales and Growth Rate (2013-2018)
6.5 Russia Bio Simulation Sales and Growth Rate (2013-2018)
6.6 Italy Bio Simulation Sales and Growth Rate (2013-2018)
7 Asia-Pacific Bio Simulation by Countries
7.1 Asia-Pacific Bio Simulation Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Bio Simulation Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Bio Simulation Revenue and Market Share by Countries (2013-2018)
7.2 China Bio Simulation Sales and Growth Rate (2013-2018)
7.3 Japan Bio Simulation Sales and Growth Rate (2013-2018)
7.4 Korea Bio Simulation Sales and Growth Rate (2013-2018)
7.5 India Bio Simulation Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Bio Simulation Sales and Growth Rate (2013-2018)
8 South America Bio Simulation by Countries
8.1 South America Bio Simulation Sales, Revenue and Market Share by Countries
8.1.1 South America Bio Simulation Sales and Market Share by Countries (2013-2018)
8.1.2 South America Bio Simulation Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Bio Simulation Sales and Growth Rate (2013-2018)
8.3 Argentina Bio Simulation Sales and Growth Rate (2013-2018)
8.4 Colombia Bio Simulation Sales and Growth Rate (2013-2018)
9 Middle East and Africa Bio Simulation by Countries
9.1 Middle East and Africa Bio Simulation Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Bio Simulation Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Bio Simulation Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Bio Simulation Sales and Growth Rate (2013-2018)
9.3 UAE Bio Simulation Sales and Growth Rate (2013-2018)
9.4 Egypt Bio Simulation Sales and Growth Rate (2013-2018)
9.5 Nigeria Bio Simulation Sales and Growth Rate (2013-2018)
9.6 South Africa Bio Simulation Sales and Growth Rate (2013-2018)
10 Global Bio Simulation Market Segment by Type
10.1 Global Bio Simulation Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Bio Simulation Sales and Market Share by Type (2013-2018)
10.1.2 Global Bio Simulation Revenue and Market Share by Type (2013-2018)
10.2 For Drug Development Sales Growth and Price
10.2.1 Global For Drug Development Sales Growth (2013-2018)
10.2.2 Global For Drug Development Price (2013-2018)
10.3 For Drug Discovery Sales Growth and Price
10.3.1 Global For Drug Discovery Sales Growth (2013-2018)
10.3.2 Global For Drug Discovery Price (2013-2018)
10.4 Other Sales Growth and Price
10.4.1 Global Other Sales Growth (2013-2018)
10.4.2 Global Other Price (2013-2018)
11 Global Bio Simulation Market Segment by Application
11.1 Global Bio Simulation Sales Market Share by Application (2013-2018)
11.2 Pharmaceutical and Biotechnology Companies Sales Growth (2013-2018)
11.3 Academic and Government Research Institutes Sales Growth (2013-2018)
11.4 Contract Research Organizations Sales Growth (2013-2018)
11.5 Regulatory Authorities Sales Growth (2013-2018)
11.6 Other End Users Sales Growth (2013-2018)
12 Bio Simulation Market Forecast (2018-2023)
12.1 Global Bio Simulation Sales, Revenue and Growth Rate (2018-2023)
12.2 Bio Simulation Market Forecast by Regions (2018-2023)
12.2.1 North America Bio Simulation Market Forecast (2018-2023)
12.2.2 Europe Bio Simulation Market Forecast (2018-2023)
12.2.3 Asia-Pacific Bio Simulation Market Forecast (2018-2023)
12.2.4 South America Bio Simulation Market Forecast (2018-2023)
12.2.5 Middle East and Africa Bio Simulation Market Forecast (2018-2023)
12.3 Bio Simulation Market Forecast by Type (2018-2023)
12.3.1 Global Bio Simulation Sales Forecast by Type (2018-2023)
12.3.2 Global Bio Simulation Market Share Forecast by Type (2018-2023)
12.4 Bio Simulation Market Forecast by Application (2018-2023)
12.4.1 Global Bio Simulation Sales Forecast by Application (2018-2023)
12.4.2 Global Bio Simulation Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Bio Simulation Picture
Table Product Specifications of Bio Simulation
Figure Global Sales Market Share of Bio Simulation by Types in 2017
Table Bio Simu